In vitiligo lesions, the levels of bFGF, SCF, ET-1, GM-CSF, and α-melanocyte-stimulating hormone (α-MSH), released by keratinocytes and fibroblasts, are lower compared to healthy controls. This evidence concerns the gene KITLG and vitiligo.